{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:33:20Z","timestamp":1762659200773},"reference-count":43,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.2217\/imt.12.93","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T17:44:10Z","timestamp":1349804650000},"page":"939-945","source":"Crossref","is-referenced-by-count":14,"title":["Randomized, Vehicle-Controlled Trials of Topical 5-Fluorouracil Therapy for Actinic Keratosis Treatment: An Overview"],"prefix":"10.1080","volume":"4","author":[{"given":"Maral","family":"Rahvar","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of California, 90 Medical Center Way, Surge 110, Box 0989, San Francisco, CA94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia A","family":"Lamel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, 90 Medical Center Way, Surge 110, Box 0989, San Francisco, CA94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard I","family":"Maibach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, 90 Medical Center Way, Surge 110, Box 0989, San Francisco, CA94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"crossref","unstructured":"MacKie RM QuinnAG. Non-melanoma skin cancer and other epidermal skin tumours. In: Rook\u2018s Textbook of Dermatology(Volume 2). Burns T Breathnach S Cox N Griffiths C (Eds). Blackwell Publishing Oxford UK 36\u201350 (2004).","DOI":"10.1002\/9780470750520.ch36"},{"issue":"4","key":"e_1_3_3_3_2_1","first-page":"201","volume":"87","author":"Feldman SR","year":"2011","unstructured":"Feldman SR , FleischerAB. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis87(4) , 201\u2013207 (2011).","journal-title":"Cutis"},{"issue":"6","key":"e_1_3_3_3_3_1","first-page":"509","volume":"81","author":"Menter A","year":"2008","unstructured":"Menter A , VamvakiasG, JorizzoJ. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. Cutis81(6) , 509\u2013516 (2008).","journal-title":"Cutis"},{"issue":"6","key":"e_1_3_3_3_4_1","first-page":"599","volume":"16","author":"Stockfleth E","year":"2006","unstructured":"Stockfleth E , KerlH. Guidelines for the management of actinic keratoses. Eur. J. Dermatol.16(6) , 599\u2013606 (2006).","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00048.x"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103343"},{"key":"e_1_3_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103342"},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2007.00339.x"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103339"},{"key":"e_1_3_3_3_10_1","first-page":"8","volume":"70","author":"Gupta AK","year":"2002","unstructured":"Gupta AK , CooperEA, FeldmanSR, FleischerAB. A survey of office visits for actinic keratosis as reported by NAMCS, 1990\u20131999. National Ambulatory Medical Care Survey. Cutis70(Suppl. 2) , 8\u201313 (2002).","journal-title":"Cutis"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08544.x"},{"issue":"7","key":"e_1_3_3_3_12_1","first-page":"539","volume":"36","author":"Chia A","year":"2007","unstructured":"Chia A , MorenoG, LimA, ShumackS. Actinic keratoses. Aust. Fam. Physician36(7) , 539\u2013543 (2007).","journal-title":"Aust. Fam. Physician"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Farage MA MillerKW MaibachHI. Neoplastic skin cancer. In: Textbook of Aging Skin. Springer Berlin Germany 547\u2013548 (2010).","DOI":"10.1007\/978-3-540-89656-2"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08267.x"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.06.009"},{"key":"e_1_3_3_3_16_1","unstructured":"Garcia M JemalA WardEM et al. Global Cancer Facts & Figures 2007. American Cancer Society GA USA (2007)."},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24284"},{"issue":"2","key":"e_1_3_3_3_18_1","first-page":"22","volume":"1","author":"Werschler WP","year":"2008","unstructured":"Werschler WP . Considerations for use of fluorouracil cream 0.5% for the treatment of actinic keratosis in elderly patients. J. Clin. Aesthet. Dermatol.1(2) , 22\u201327 (2008).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90191-4"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1962.tb13497.x"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2004.06.005"},{"issue":"2","key":"e_1_3_3_3_22_1","first-page":"133","volume":"5","author":"Jorizzo J","year":"2006","unstructured":"Jorizzo J , WeissJ, VamvakiasG. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study. J. Drugs Dermatol.5(2) , 133\u2013139 (2006).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.7.813"},{"key":"e_1_3_3_3_24_1","first-page":"22","article-title":"Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.","volume":"70","author":"Weiss J","year":"2002","unstructured":"Weiss J , MenterA, HeviaO et al. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis 70(Suppl. 2) , 22\u201329 (2002).","journal-title":"Cutis"},{"issue":"6","key":"e_1_3_3_3_25_1","first-page":"335","article-title":"Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.","volume":"70","author":"Jorizzo J","year":"2002","unstructured":"Jorizzo J , StewartD, BuckoA et al. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis 70(6) , 335\u2013339 (2002).","journal-title":"Cutis"},{"key":"e_1_3_3_3_26_1","first-page":"131","author":"Pattison DI","year":"2006","unstructured":"Pattison DI , DaviesMJ. Actions of ultraviolet light on cellular structures. EXS (96) , 131\u2013157 (2006).","journal-title":"EXS"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(94)90234-8"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000076016"},{"key":"e_1_3_3_3_29_1","first-page":"18","volume":"79","author":"Newman MD","year":"2007","unstructured":"Newman MD , WeinbergJM. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma. Cutis79(Suppl. 4) , 18\u201328 (2007).","journal-title":"Cutis"},{"key":"e_1_3_3_3_30_1","first-page":"4","volume":"70","author":"Robins P","year":"2002","unstructured":"Robins P , GuptaAK. The use of topical fluorouracil to treat actinic keratosis. Cutis70(Suppl. 2) , 4\u20137 (2002).","journal-title":"Cutis"},{"key":"e_1_3_3_3_31_1","unstructured":"Maibach H GorouhiF . Treatment of actinic keratosis. In: Evidence Based Dermatology. Carlson S Borrdeaux J (Eds). PMPH CT USA 615\u2013648 (2011)."},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80078-3"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80077-1"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.4.467"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.01.047"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.27749"},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70054-0"},{"key":"e_1_3_3_3_38_1","unstructured":"Kligman AL ThroneEG. Topical therapy of actinic keratosis with tretinoin. In: Retinoid in Cutaneous Malignancy. Marks R (Ed.). Blackwell Scientific Publications Oxford UK 66\u201373 (1991)."},{"issue":"8","key":"e_1_3_3_3_39_1","first-page":"1055","article-title":"Reliability of counting actinic keratoses before and after brief consensus discussion: the VA Topical Tretinoin Chemoprevention (VATTC) trial.","volume":"137","author":"Weinstock MA","year":"2001","unstructured":"Weinstock MA , BinghamSF, ColeGW et al. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA Topical Tretinoin Chemoprevention (VATTC) trial. Arch. Dermatol. 137(8) , 1055\u20131058 (2001).","journal-title":"Arch. Dermatol."},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700110"},{"key":"e_1_3_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903341937"},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1983.tb00256.x"},{"key":"e_1_3_3_4_2_1","unstructured":"US FDA. Carac\u2122 Cream 0.5% (fluorouracil cream). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/20985slr004_carac_lbl.pdf"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.12.93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:06:33Z","timestamp":1715972793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.12.93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.2217\/imt.12.93"],"URL":"https:\/\/doi.org\/10.2217\/imt.12.93","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}